Ritchie Torres purchased ABBV (AbbVie Inc) on Sep 26, 2024 with an estimated value between $1,000 and $15,000. This trade was filed under undisclosed. This is an options-related trade; gain/loss is not calculated.
C: This investment is held within a publicly available, widely held independently managed portfolio over which I have no authority to exercise control over or influence the financial interests held by the portfolio. The assets of the portfolio are widely diversified, and all investment decisions are made solely by the independent manager, without my input or direction.
